ROCKVILLE, Md., Oct. 24, 2014 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCBB: RGRX) ("the Company" or "RegeneRx") today reported on data presented at the Fourth International Symposium on Thymosins in Health and Disease in Rome, Italy. "When thymosin beta 4...
Reported by PR Newswire 25 minutes ago.
↧